Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors

Maurizio Chiriva-Internati, Fabio Grizzi, Justin Pinkston, K. John Morrow, Nicholas D'Cunha, Eldo E. Frezza, Pier Carlo Muzzio, W. Martin Kast, Everardo Cobos

Research output: Contribution to journalArticle

Abstract

The γ-irradiation of normal cells causes an increased synthesis of specific proteins. However, few studies have described the effects of high doses of irradiation on the expression of cell surface antigens in tumor cells. This study analyzed the effects of high doses of γ-irradiation on the surface antigen expression of Major Histocompatability Complex (MHC) class I/II and intercellular adhesion molecule-1 (ICAM-I) in human multiple myeloma (MM) cell lines ARP-1, ARK-RS, and 10 MM primary tumors. The expression of surface antigens was evaluated by fluorescence-activated cell sorter analysis at different time points, following the exposure to high doses of γ-irradiation. Doses of 10,000 and 15,000 cGy were not sufficient to totally block cell replication in both cell lines and primary tumors; cell replication was able to be inhibited completely only at 18,000 cGy. Lower doses (10,000 cGy) and lethal doses of irradiation (i.e., 15,000 and 18,000 cGy) increased the expression of all surface antigens present on the cells before irradiation. Essentially, such upregulation was shown to be dose dependent, with higher radiation doses resulting in higher antigen expression. Furthermore, when the kinetics of this upregulation were studied 3 and 6 d after irradiation, there was a constant increase in antigen expression in MM cells. These findings suggest that upregulation of costimulatory molecules, such as of MHC class I/II antigens and ICAM-I molecules in MM patients treated by γ-radiation, can increase the immunogenicity of the tumor cells. In light of these findings, radiotherapy combined with immunotherapy might be considered in relapsing patients after receiving the standard treatment.

Original languageEnglish
Pages (from-to)89-95
Number of pages7
JournalIn Vitro Cellular & Developmental Biology - Animal
Volume42
Issue number3-4
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Gamma Rays
Tumor Cell Line
Multiple Myeloma
Gamma rays
Dosimetry
Tumors
Up-Regulation
Cells
Irradiation
Molecules
Surface Antigens
Antigens
Radiation
Neoplasms
Radiotherapy
Histocompatibility Antigens Class I
Intercellular Adhesion Molecule-1
Histocompatibility Antigens Class II
Immunotherapy
Fluorescence

Keywords

  • gamma irradiation
  • MHC
  • Multiple myeloma
  • Radiotherapy
  • Tumor

ASJC Scopus subject areas

  • Developmental Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors. / Chiriva-Internati, Maurizio; Grizzi, Fabio; Pinkston, Justin; Morrow, K. John; D'Cunha, Nicholas; Frezza, Eldo E.; Muzzio, Pier Carlo; Kast, W. Martin; Cobos, Everardo.

In: In Vitro Cellular & Developmental Biology - Animal, Vol. 42, No. 3-4, 03.2006, p. 89-95.

Research output: Contribution to journalArticle

Chiriva-Internati, M, Grizzi, F, Pinkston, J, Morrow, KJ, D'Cunha, N, Frezza, EE, Muzzio, PC, Kast, WM & Cobos, E 2006, 'Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors', In Vitro Cellular & Developmental Biology - Animal, vol. 42, no. 3-4, pp. 89-95. https://doi.org/10.1290/0508054.1
Chiriva-Internati, Maurizio ; Grizzi, Fabio ; Pinkston, Justin ; Morrow, K. John ; D'Cunha, Nicholas ; Frezza, Eldo E. ; Muzzio, Pier Carlo ; Kast, W. Martin ; Cobos, Everardo. / Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors. In: In Vitro Cellular & Developmental Biology - Animal. 2006 ; Vol. 42, No. 3-4. pp. 89-95.
@article{75292071b4194ae297a2c2541b0c2b02,
title = "Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors",
abstract = "The γ-irradiation of normal cells causes an increased synthesis of specific proteins. However, few studies have described the effects of high doses of irradiation on the expression of cell surface antigens in tumor cells. This study analyzed the effects of high doses of γ-irradiation on the surface antigen expression of Major Histocompatability Complex (MHC) class I/II and intercellular adhesion molecule-1 (ICAM-I) in human multiple myeloma (MM) cell lines ARP-1, ARK-RS, and 10 MM primary tumors. The expression of surface antigens was evaluated by fluorescence-activated cell sorter analysis at different time points, following the exposure to high doses of γ-irradiation. Doses of 10,000 and 15,000 cGy were not sufficient to totally block cell replication in both cell lines and primary tumors; cell replication was able to be inhibited completely only at 18,000 cGy. Lower doses (10,000 cGy) and lethal doses of irradiation (i.e., 15,000 and 18,000 cGy) increased the expression of all surface antigens present on the cells before irradiation. Essentially, such upregulation was shown to be dose dependent, with higher radiation doses resulting in higher antigen expression. Furthermore, when the kinetics of this upregulation were studied 3 and 6 d after irradiation, there was a constant increase in antigen expression in MM cells. These findings suggest that upregulation of costimulatory molecules, such as of MHC class I/II antigens and ICAM-I molecules in MM patients treated by γ-radiation, can increase the immunogenicity of the tumor cells. In light of these findings, radiotherapy combined with immunotherapy might be considered in relapsing patients after receiving the standard treatment.",
keywords = "gamma irradiation, MHC, Multiple myeloma, Radiotherapy, Tumor",
author = "Maurizio Chiriva-Internati and Fabio Grizzi and Justin Pinkston and Morrow, {K. John} and Nicholas D'Cunha and Frezza, {Eldo E.} and Muzzio, {Pier Carlo} and Kast, {W. Martin} and Everardo Cobos",
year = "2006",
month = "3",
doi = "10.1290/0508054.1",
language = "English",
volume = "42",
pages = "89--95",
journal = "In Vitro Cellular and Developmental Biology - Animal",
issn = "1071-2690",
publisher = "Springer New York",
number = "3-4",

}

TY - JOUR

T1 - Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors

AU - Chiriva-Internati, Maurizio

AU - Grizzi, Fabio

AU - Pinkston, Justin

AU - Morrow, K. John

AU - D'Cunha, Nicholas

AU - Frezza, Eldo E.

AU - Muzzio, Pier Carlo

AU - Kast, W. Martin

AU - Cobos, Everardo

PY - 2006/3

Y1 - 2006/3

N2 - The γ-irradiation of normal cells causes an increased synthesis of specific proteins. However, few studies have described the effects of high doses of irradiation on the expression of cell surface antigens in tumor cells. This study analyzed the effects of high doses of γ-irradiation on the surface antigen expression of Major Histocompatability Complex (MHC) class I/II and intercellular adhesion molecule-1 (ICAM-I) in human multiple myeloma (MM) cell lines ARP-1, ARK-RS, and 10 MM primary tumors. The expression of surface antigens was evaluated by fluorescence-activated cell sorter analysis at different time points, following the exposure to high doses of γ-irradiation. Doses of 10,000 and 15,000 cGy were not sufficient to totally block cell replication in both cell lines and primary tumors; cell replication was able to be inhibited completely only at 18,000 cGy. Lower doses (10,000 cGy) and lethal doses of irradiation (i.e., 15,000 and 18,000 cGy) increased the expression of all surface antigens present on the cells before irradiation. Essentially, such upregulation was shown to be dose dependent, with higher radiation doses resulting in higher antigen expression. Furthermore, when the kinetics of this upregulation were studied 3 and 6 d after irradiation, there was a constant increase in antigen expression in MM cells. These findings suggest that upregulation of costimulatory molecules, such as of MHC class I/II antigens and ICAM-I molecules in MM patients treated by γ-radiation, can increase the immunogenicity of the tumor cells. In light of these findings, radiotherapy combined with immunotherapy might be considered in relapsing patients after receiving the standard treatment.

AB - The γ-irradiation of normal cells causes an increased synthesis of specific proteins. However, few studies have described the effects of high doses of irradiation on the expression of cell surface antigens in tumor cells. This study analyzed the effects of high doses of γ-irradiation on the surface antigen expression of Major Histocompatability Complex (MHC) class I/II and intercellular adhesion molecule-1 (ICAM-I) in human multiple myeloma (MM) cell lines ARP-1, ARK-RS, and 10 MM primary tumors. The expression of surface antigens was evaluated by fluorescence-activated cell sorter analysis at different time points, following the exposure to high doses of γ-irradiation. Doses of 10,000 and 15,000 cGy were not sufficient to totally block cell replication in both cell lines and primary tumors; cell replication was able to be inhibited completely only at 18,000 cGy. Lower doses (10,000 cGy) and lethal doses of irradiation (i.e., 15,000 and 18,000 cGy) increased the expression of all surface antigens present on the cells before irradiation. Essentially, such upregulation was shown to be dose dependent, with higher radiation doses resulting in higher antigen expression. Furthermore, when the kinetics of this upregulation were studied 3 and 6 d after irradiation, there was a constant increase in antigen expression in MM cells. These findings suggest that upregulation of costimulatory molecules, such as of MHC class I/II antigens and ICAM-I molecules in MM patients treated by γ-radiation, can increase the immunogenicity of the tumor cells. In light of these findings, radiotherapy combined with immunotherapy might be considered in relapsing patients after receiving the standard treatment.

KW - gamma irradiation

KW - MHC

KW - Multiple myeloma

KW - Radiotherapy

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=33747616867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747616867&partnerID=8YFLogxK

U2 - 10.1290/0508054.1

DO - 10.1290/0508054.1

M3 - Article

C2 - 16759154

AN - SCOPUS:33747616867

VL - 42

SP - 89

EP - 95

JO - In Vitro Cellular and Developmental Biology - Animal

JF - In Vitro Cellular and Developmental Biology - Animal

SN - 1071-2690

IS - 3-4

ER -